Concepedia
Statistics
Publications
41
Citations
2.4K
H-Index
27
Active since
1951
Affiliations
New Frontier(Current)
GlaxoSmithKline (United States)
GlaxoSmithKline (United Kingdom)
South College
University of Toledo
Charles B. Davis is an author at New Frontier specializing in pharmacology, pharmacy, and medicine.
Publications per year
1951–2024
Recombinant Human Erythropoietin Stimulates Erythropoiesis and Reduces Erythrocyte Transfusions in Very Low Birth Weight Preterm Infants
Kevin Shannon, Julian F. Keith, William C. Mentzer et al. · PEDIATRICS · 1995 · 323 citations
Medicine, Hematology, Pediatrics +17
Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management
Richard Kowalski, Diane R. Post, Mary C Schneider et al. · Clinical Transplantation · 2003 · 262 citations · Full text
Medicine, Immunology, Pharmacology +17
Enzyme-Mediated Methodology for the Site-Specific Radiolabeling of Antibodies Based on Catalyst-Free Click Chemistry
Brian M. Zeglis, Charles B. Davis, Robert Aggeler et al. · Bioconjugate Chemistry · 2013 · 158 citations · Full text
Pharmacy, Biochemistry, Molecular Pharmaceutics +17
The influence of ionic strength on the binding of a water soluble porphyrin to nucleic acids
Robert F. Pasternack, Paul Garrity, Bruce Ehrlich et al. · Nucleic Acids Research · 1986 · 98 citations · Full text
Natural Sciences, Biochemistry, Chemistry +17
A population pharmacokinetic-pharmacodynamic analysis of single doses of clenoliximab in patients with rheumatoid arthritis
Diane R. Mould, Charles B. Davis, Elisabeth A. Minthorn et al. · Clinical Pharmacology & Therapeutics · 1999 · 85 citations
Medicine, Pharmacokinetics, Pharmacology +17
1–5 of 41